BioSpace News Archive

Klick Health has been named a Best Managed Company for the 12th consecutive year.

Netherlands Cancer Institute Intends to Sponsor and Conduct Phase 1/1b SHERPA Trial in Patients with Tumors Harboring RAS Mutations

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system (CNS) disorders, today reported key business updates and financial results for the fourth quarter and fiscal year ended December 31, 2019.

Global Coronary Stent market report entitles an analysis of the market scenario, market consideration, and assumptions.

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today announced financial results for the fourth quarter ended December 31, 2019 and provided a corporate update.

CEL-SCI Corporation (NYSE American: CVM) announces that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it has appointed Jeffrey A. Bailey to its Board of Directors

Voyager Therapeutics, Inc. (NASDAQ: VYGR) announced today the cancellation of the Company’s presentation and webcast at the Barclays Global Healthcare Conference, previously scheduled to take place on March 10, 2020 at 4:20 p.m. ET.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that abstracts featuring ublituximab, the Company’s novel, glycoengineered anti-CD20 monoclonal antibody, in relapsing forms of multiple sclerosis (RMS), have been selected for presentation at the upcoming American Academy of Neurology (AAN) annual meeting, to be held April 25 – May 1, 2020, in Toronto, Canada.

Healthcare quality management aims to improve the effectiveness of treatments and increase the satisfaction of the patients with the services they are being provided with. For this purpose, various laws have been enacted by the governments all across the world so that the interests of the patients are protected.